— Know what they know.
Not Investment Advice
Also trades as: CDIO (NASDAQ) · $vol 0M

CDIOW NASDAQ

Cardio Diagnostics Holdings, Inc.
1W: -3.9% 1M: -31.5% 3M: -23.1% YTD: -54.8% 1Y: -32.0% 3Y: -79.9%
$0.01
+0.00 (+0.00%)
 
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 36 · $2.6M mcap · 2M float · 1.07% daily turnover · Short 90% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$2.6M
52W Range0.0083-0.0721
Volume13,581
Avg Volume20,569
Beta2.18
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOMeeshanthini V. Dogan
Employees15
SectorHealthcare
IndustryBiotechnology
IPO Date2022-01-14
Websitecdio.ai
311 West Superior Street
Chicago, IL 60654
US
855 226 9991
About Cardio Diagnostics Holdings, Inc.

Founded in Chicago, Illinois, in 2017, Cardio Diagnostics Holdings, Inc. specializes in the creation and market introduction of clinical tests. These diagnostic tools leverage epigenetics to assess cardiovascular disease risk. Among its offerings is Epi+Gen CHD, a test designed to predict the risk of symptomatic coronary heart disease over a three-year timeframe.

Recent Insider Trades

NameTypeSharesPriceDate
Fung Peter K A-Award 18,939 $0.33 2025-03-31
Betts Wendy J A-Award 18,939 $0.33 2025-03-31
Burton Paul Frederic A-Award 18,939 $0.33 2025-03-31
Intrater James A-Award 18,939 $0.33 2025-03-31
Fung Peter K 2,272 $0.92 2024-12-31

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms